Patent · US Active

Immunoglobulin single variable domains directed against macrophage migration inhibitory factor

US11098113B2 · kind B2 · utility

0Cited by

1References

11Claims

0Family size

Assignees

VIB VZW · BE
VRIJE UNIVERSITEIT BRUSSEL · BE

Inventors

Peter Vanlandschoot · Bellem, BE
Ines Cabrito · Porto, PT
Benoît Stijlemans · Kampenhout, BE
Amanda Sparkes · Mechelen, BE
Jo Van Ginderachter · Ninove, BE
Patrick De Baetselier · Berchem, BE

Key dates

Filing date	Sep 15, 2017
Grant date	Aug 24, 2021
Priority date	—
Expiry date	Dec 11, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to immunoglobulin single variable domains that bind MIF and more in particular to polypeptides that comprise or essentially consist of one or more such immunoglobulin single variable domains; to nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.